✦ LIBER ✦

No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants

✍ Scribed by Lucio Caccamo; Raffaella Romeo; Giorgio Rossi; Mauro Maggioni; Ferdinando Radice; Giovanna Lunghi; Massimo Colombo; Luigi R. Fassati

Book ID: 110916284
Publisher: Springer
Year: 2005
Tongue: English
Weight: 80 KB
Volume: 18
Category: Article
ISSN: 0934-0874
DOI: 10.1111/j.1432-2277.2004.00034.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prophylaxis of Recurrent Hepatitis B in

Prophylaxis of Recurrent Hepatitis B in Chinese Patients After Liver Transplantation Using Lamivudine Combined With Hepatitis B Immune Globulin According to the Titer of Antibody to Hepatitis B Surface Antigen

✍ Z.-Y. Jiao; L.-N. Yan; B. Li; Y. Zeng; T.-F. Wen; S.-C. Lu; J.-C. Zhao; W.-T. Wa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Lamivudine therapy in patients undergoin

Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu

✍ McCaughan, Geoffrey W. ;Spencer, Jenean ;Koorey, David ;Bowden, Scott ;Bartholom 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 75 KB 👁 1 views

Recurrent hepatitis B virus (HBV) infection remains a major cause of morbidity and mortality after liver transplantation. Recently, antiviral therapy, such as lamivudine, has become available for prophylaxis against HBV reactivation posttransplantation and for the treatment of HBV recurrent disease.

Prediction of sustained virological resp

Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing

✍ Guy W. Neff; Christopher B. O'Brien; Robert Cirocco; Marzia Montalbano; Maria de 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

The optimal duration of therapy for pegylated interferon combined with ribavirin in recurrent Hepatitis C virus (HCV) following liver transplantation is not known. We wanted to determine if testing for HCV in liver tissue by reverse transcriptase polymerase chain reaction (RT-PCR) was superior in pr